杭州泰格医药科技股份有限公司（「泰格医药」或「公司」，A股代码：300347，H股代码：03347）于2025年12月3日公布截至2025年11月30日的股份变动月报表。报告显示，公司本月无新增发行股份或注销行为，整体股本结构保持稳定。
根据公告，公司法定/注册股本于期末合计人民币861,026,050元。其中，A股法定/注册股数为737,901,250股，面值每股人民币1元；H股法定/注册股数为123,124,800股，面值每股人民币1元。各类股份于本月均无增减变动。
已发行股份方面，A股于期末普通股数量为732,017,470股，库藏股数量为5,883,780股，总数保持在737,901,250股；H股则继续维持123,124,800股，且无库藏股。公告说明，前期曾购回并注销部分A股，截至本月末，公司仍持有5,883,780股库藏A股，未发生新增买回或注销。
公告结尾称，截至2025年11月30日，公司股本总数稳定，无新增发行、购回或注销活动。该月报由公司董事叶小平签署，公司称将继续遵守香港联合交易所有限公司证券上市规则及相关法律法规。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.